Global Central Nervous System (CNS) Drug Market Size, Status and Forecast 2021-2027

Global Central Nervous System (CNS) Drug Market Size, Status and Forecast 2021-2027

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Central Nervous System (CNS) Drug Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Prescription Drugs
1.2.3 OTC
1.3 Market by Application
1.3.1 Global Central Nervous System (CNS) Drug Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 MS Therapeutics
1.3.3 Antipsychotic Drugs
1.3.4 Depression Drugs
1.3.5 Epilepsy Drugs
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Central Nervous System (CNS) Drug Market Perspective (2016-2027)
2.2 Central Nervous System (CNS) Drug Growth Trends by Regions
2.2.1 Central Nervous System (CNS) Drug Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Central Nervous System (CNS) Drug Historic Market Share by Regions (2016-2021)
2.2.3 Central Nervous System (CNS) Drug Forecasted Market Size by Regions (2022-2027)
2.3 Central Nervous System (CNS) Drug Industry Dynamic
2.3.1 Central Nervous System (CNS) Drug Market Trends
2.3.2 Central Nervous System (CNS) Drug Market Drivers
2.3.3 Central Nervous System (CNS) Drug Market Challenges
2.3.4 Central Nervous System (CNS) Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Central Nervous System (CNS) Drug Players by Revenue
3.1.1 Global Top Central Nervous System (CNS) Drug Players by Revenue (2016-2021)
3.1.2 Global Central Nervous System (CNS) Drug Revenue Market Share by Players (2016-2021)
3.2 Global Central Nervous System (CNS) Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Central Nervous System (CNS) Drug Revenue
3.4 Global Central Nervous System (CNS) Drug Market Concentration Ratio
3.4.1 Global Central Nervous System (CNS) Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Central Nervous System (CNS) Drug Revenue in 2020
3.5 Central Nervous System (CNS) Drug Key Players Head office and Area Served
3.6 Key Players Central Nervous System (CNS) Drug Product Solution and Service
3.7 Date of Enter into Central Nervous System (CNS) Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Central Nervous System (CNS) Drug Breakdown Data by Type
4.1 Global Central Nervous System (CNS) Drug Historic Market Size by Type (2016-2021)
4.2 Global Central Nervous System (CNS) Drug Forecasted Market Size by Type (2022-2027)
5 Central Nervous System (CNS) Drug Breakdown Data by Application
5.1 Global Central Nervous System (CNS) Drug Historic Market Size by Application (2016-2021)
5.2 Global Central Nervous System (CNS) Drug Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Central Nervous System (CNS) Drug Market Size (2016-2027)
6.2 North America Central Nervous System (CNS) Drug Market Size by Type
6.2.1 North America Central Nervous System (CNS) Drug Market Size by Type (2016-2021)
6.2.2 North America Central Nervous System (CNS) Drug Market Size by Type (2022-2027)
6.2.3 North America Central Nervous System (CNS) Drug Market Size by Type (2016-2027)
6.3 North America Central Nervous System (CNS) Drug Market Size by Application
6.3.1 North America Central Nervous System (CNS) Drug Market Size by Application (2016-2021)
6.3.2 North America Central Nervous System (CNS) Drug Market Size by Application (2022-2027)
6.3.3 North America Central Nervous System (CNS) Drug Market Size by Application (2016-2027)
6.4 North America Central Nervous System (CNS) Drug Market Size by Country
6.4.1 North America Central Nervous System (CNS) Drug Market Size by Country (2016-2021)
6.4.2 North America Central Nervous System (CNS) Drug Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Central Nervous System (CNS) Drug Market Size (2016-2027)
7.2 Europe Central Nervous System (CNS) Drug Market Size by Type
7.2.1 Europe Central Nervous System (CNS) Drug Market Size by Type (2016-2021)
7.2.2 Europe Central Nervous System (CNS) Drug Market Size by Type (2022-2027)
7.2.3 Europe Central Nervous System (CNS) Drug Market Size by Type (2016-2027)
7.3 Europe Central Nervous System (CNS) Drug Market Size by Application
7.3.1 Europe Central Nervous System (CNS) Drug Market Size by Application (2016-2021)
7.3.2 Europe Central Nervous System (CNS) Drug Market Size by Application (2022-2027)
7.3.3 Europe Central Nervous System (CNS) Drug Market Size by Application (2016-2027)
7.4 Europe Central Nervous System (CNS) Drug Market Size by Country
7.4.1 Europe Central Nervous System (CNS) Drug Market Size by Country (2016-2021)
7.4.2 Europe Central Nervous System (CNS) Drug Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Central Nervous System (CNS) Drug Market Size (2016-2027)
8.2 Asia-Pacific Central Nervous System (CNS) Drug Market Size by Type
8.2.1 Asia-Pacific Central Nervous System (CNS) Drug Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Central Nervous System (CNS) Drug Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Central Nervous System (CNS) Drug Market Size by Type (2016-2027)
8.3 Asia-Pacific Central Nervous System (CNS) Drug Market Size by Application
8.3.1 Asia-Pacific Central Nervous System (CNS) Drug Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Central Nervous System (CNS) Drug Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Central Nervous System (CNS) Drug Market Size by Application (2016-2027)
8.4 Asia-Pacific Central Nervous System (CNS) Drug Market Size by Region
8.4.1 Asia-Pacific Central Nervous System (CNS) Drug Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Central Nervous System (CNS) Drug Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Central Nervous System (CNS) Drug Market Size (2016-2027)
9.2 Latin America Central Nervous System (CNS) Drug Market Size by Type
9.2.1 Latin America Central Nervous System (CNS) Drug Market Size by Type (2016-2021)
9.2.2 Latin America Central Nervous System (CNS) Drug Market Size by Type (2022-2027)
9.2.3 Latin America Central Nervous System (CNS) Drug Market Size by Type (2016-2027)
9.3 Latin America Central Nervous System (CNS) Drug Market Size by Application
9.3.1 Latin America Central Nervous System (CNS) Drug Market Size by Application (2016-2021)
9.3.2 Latin America Central Nervous System (CNS) Drug Market Size by Application (2022-2027)
9.3.3 Latin America Central Nervous System (CNS) Drug Market Size by Application (2016-2027)
9.4 Latin America Central Nervous System (CNS) Drug Market Size by Country
9.4.1 Latin America Central Nervous System (CNS) Drug Market Size by Country (2016-2021)
9.4.2 Latin America Central Nervous System (CNS) Drug Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Central Nervous System (CNS) Drug Market Size (2016-2027)
10.2 Middle East & Africa Central Nervous System (CNS) Drug Market Size by Type
10.2.1 Middle East & Africa Central Nervous System (CNS) Drug Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Central Nervous System (CNS) Drug Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Central Nervous System (CNS) Drug Market Size by Type (2016-2027)
10.3 Middle East & Africa Central Nervous System (CNS) Drug Market Size by Application
10.3.1 Middle East & Africa Central Nervous System (CNS) Drug Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Central Nervous System (CNS) Drug Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Central Nervous System (CNS) Drug Market Size by Application (2016-2027)
10.4 Middle East & Africa Central Nervous System (CNS) Drug Market Size by Country
10.4.1 Middle East & Africa Central Nervous System (CNS) Drug Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Central Nervous System (CNS) Drug Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Details
11.1.2 Johnson & Johnson Business Overview
11.1.3 Johnson & Johnson Central Nervous System (CNS) Drug Introduction
11.1.4 Johnson & Johnson Revenue in Central Nervous System (CNS) Drug Business (2016-2021)
11.1.5 Johnson & Johnson Recent Development
11.2 Pfizer Inc
11.2.1 Pfizer Inc Company Details
11.2.2 Pfizer Inc Business Overview
11.2.3 Pfizer Inc Central Nervous System (CNS) Drug Introduction
11.2.4 Pfizer Inc Revenue in Central Nervous System (CNS) Drug Business (2016-2021)
11.2.5 Pfizer Inc Recent Development
11.3 Novartis AG
11.3.1 Novartis AG Company Details
11.3.2 Novartis AG Business Overview
11.3.3 Novartis AG Central Nervous System (CNS) Drug Introduction
11.3.4 Novartis AG Revenue in Central Nervous System (CNS) Drug Business (2016-2021)
11.3.5 Novartis AG Recent Development
11.4 GSK
11.4.1 GSK Company Details
11.4.2 GSK Business Overview
11.4.3 GSK Central Nervous System (CNS) Drug Introduction
11.4.4 GSK Revenue in Central Nervous System (CNS) Drug Business (2016-2021)
11.4.5 GSK Recent Development
11.5 Eli Lilly
11.5.1 Eli Lilly Company Details
11.5.2 Eli Lilly Business Overview
11.5.3 Eli Lilly Central Nervous System (CNS) Drug Introduction
11.5.4 Eli Lilly Revenue in Central Nervous System (CNS) Drug Business (2016-2021)
11.5.5 Eli Lilly Recent Development
11.6 Teva
11.6.1 Teva Company Details
11.6.2 Teva Business Overview
11.6.3 Teva Central Nervous System (CNS) Drug Introduction
11.6.4 Teva Revenue in Central Nervous System (CNS) Drug Business (2016-2021)
11.6.5 Teva Recent Development
11.7 Otsuka Pharmaceutical Co., Ltd
11.7.1 Otsuka Pharmaceutical Co., Ltd Company Details
11.7.2 Otsuka Pharmaceutical Co., Ltd Business Overview
11.7.3 Otsuka Pharmaceutical Co., Ltd Central Nervous System (CNS) Drug Introduction
11.7.4 Otsuka Pharmaceutical Co., Ltd Revenue in Central Nervous System (CNS) Drug Business (2016-2021)
11.7.5 Otsuka Pharmaceutical Co., Ltd Recent Development
11.8 Biogen Inc
11.8.1 Biogen Inc Company Details
11.8.2 Biogen Inc Business Overview
11.8.3 Biogen Inc Central Nervous System (CNS) Drug Introduction
11.8.4 Biogen Inc Revenue in Central Nervous System (CNS) Drug Business (2016-2021)
11.8.5 Biogen Inc Recent Development
11.9 Boehringer Ingelheim
11.9.1 Boehringer Ingelheim Company Details
11.9.2 Boehringer Ingelheim Business Overview
11.9.3 Boehringer Ingelheim Central Nervous System (CNS) Drug Introduction
11.9.4 Boehringer Ingelheim Revenue in Central Nervous System (CNS) Drug Business (2016-2021)
11.9.5 Boehringer Ingelheim Recent Development
11.10 Roche
11.10.1 Roche Company Details
11.10.2 Roche Business Overview
11.10.3 Roche Central Nervous System (CNS) Drug Introduction
11.10.4 Roche Revenue in Central Nervous System (CNS) Drug Business (2016-2021)
11.10.5 Roche Recent Development
11.11 UCB
11.11.1 UCB Company Details
11.11.2 UCB Business Overview
11.11.3 UCB Central Nervous System (CNS) Drug Introduction
11.11.4 UCB Revenue in Central Nervous System (CNS) Drug Business (2016-2021)
11.11.5 UCB Recent Development
11.12 Tekeda
11.12.1 Tekeda Company Details
11.12.2 Tekeda Business Overview
11.12.3 Tekeda Central Nervous System (CNS) Drug Introduction
11.12.4 Tekeda Revenue in Central Nervous System (CNS) Drug Business (2016-2021)
11.12.5 Tekeda Recent Development
11.13 Shanghai Fosun
11.13.1 Shanghai Fosun Company Details
11.13.2 Shanghai Fosun Business Overview
11.13.3 Shanghai Fosun Central Nervous System (CNS) Drug Introduction
11.13.4 Shanghai Fosun Revenue in Central Nervous System (CNS) Drug Business (2016-2021)
11.13.5 Shanghai Fosun Recent Development
11.14 Jiangsu Nhwa Pharmaceutical Co., Ltd.
11.14.1 Jiangsu Nhwa Pharmaceutical Co., Ltd. Company Details
11.14.2 Jiangsu Nhwa Pharmaceutical Co., Ltd. Business Overview
11.14.3 Jiangsu Nhwa Pharmaceutical Co., Ltd. Central Nervous System (CNS) Drug Introduction
11.14.4 Jiangsu Nhwa Pharmaceutical Co., Ltd. Revenue in Central Nervous System (CNS) Drug Business (2016-2021)
11.14.5 Jiangsu Nhwa Pharmaceutical Co., Ltd. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Central Nervous System (CNS) Drug Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Prescription Drugs
Table 3. Key Players of OTC
Table 4. Global Central Nervous System (CNS) Drug Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Central Nervous System (CNS) Drug Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Central Nervous System (CNS) Drug Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Central Nervous System (CNS) Drug Market Share by Regions (2016-2021)
Table 8. Global Central Nervous System (CNS) Drug Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Central Nervous System (CNS) Drug Market Share by Regions (2022-2027)
Table 10. Central Nervous System (CNS) Drug Market Trends
Table 11. Central Nervous System (CNS) Drug Market Drivers
Table 12. Central Nervous System (CNS) Drug Market Challenges
Table 13. Central Nervous System (CNS) Drug Market Restraints
Table 14. Global Central Nervous System (CNS) Drug Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Central Nervous System (CNS) Drug Market Share by Players (2016-2021)
Table 16. Global Top Central Nervous System (CNS) Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Central Nervous System (CNS) Drug as of 2020)
Table 17. Ranking of Global Top Central Nervous System (CNS) Drug Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Central Nervous System (CNS) Drug Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Central Nervous System (CNS) Drug Product Solution and Service
Table 21. Date of Enter into Central Nervous System (CNS) Drug Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Central Nervous System (CNS) Drug Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Central Nervous System (CNS) Drug Revenue Market Share by Type (2016-2021)
Table 25. Global Central Nervous System (CNS) Drug Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Central Nervous System (CNS) Drug Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Central Nervous System (CNS) Drug Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Central Nervous System (CNS) Drug Revenue Market Share by Application (2016-2021)
Table 29. Global Central Nervous System (CNS) Drug Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Central Nervous System (CNS) Drug Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Central Nervous System (CNS) Drug Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Central Nervous System (CNS) Drug Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Central Nervous System (CNS) Drug Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Central Nervous System (CNS) Drug Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Central Nervous System (CNS) Drug Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Central Nervous System (CNS) Drug Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Central Nervous System (CNS) Drug Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Central Nervous System (CNS) Drug Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Central Nervous System (CNS) Drug Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Central Nervous System (CNS) Drug Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Central Nervous System (CNS) Drug Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Central Nervous System (CNS) Drug Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Central Nervous System (CNS) Drug Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Central Nervous System (CNS) Drug Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Central Nervous System (CNS) Drug Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Central Nervous System (CNS) Drug Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Central Nervous System (CNS) Drug Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Central Nervous System (CNS) Drug Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Central Nervous System (CNS) Drug Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Central Nervous System (CNS) Drug Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Central Nervous System (CNS) Drug Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Central Nervous System (CNS) Drug Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Central Nervous System (CNS) Drug Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Central Nervous System (CNS) Drug Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Central Nervous System (CNS) Drug Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Central Nervous System (CNS) Drug Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Central Nervous System (CNS) Drug Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Central Nervous System (CNS) Drug Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Central Nervous System (CNS) Drug Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Central Nervous System (CNS) Drug Market Size by Country (2022-2027) & (US$ Million)
Table 61. Johnson & Johnson Company Details
Table 62. Johnson & Johnson Business Overview
Table 63. Johnson & Johnson Central Nervous System (CNS) Drug Product
Table 64. Johnson & Johnson Revenue in Central Nervous System (CNS) Drug Business (2016-2021) & (US$ Million)
Table 65. Johnson & Johnson Recent Development
Table 66. Pfizer Inc Company Details
Table 67. Pfizer Inc Business Overview
Table 68. Pfizer Inc Central Nervous System (CNS) Drug Product
Table 69. Pfizer Inc Revenue in Central Nervous System (CNS) Drug Business (2016-2021) & (US$ Million)
Table 70. Pfizer Inc Recent Development
Table 71. Novartis AG Company Details
Table 72. Novartis AG Business Overview
Table 73. Novartis AG Central Nervous System (CNS) Drug Product
Table 74. Novartis AG Revenue in Central Nervous System (CNS) Drug Business (2016-2021) & (US$ Million)
Table 75. Novartis AG Recent Development
Table 76. GSK Company Details
Table 77. GSK Business Overview
Table 78. GSK Central Nervous System (CNS) Drug Product
Table 79. GSK Revenue in Central Nervous System (CNS) Drug Business (2016-2021) & (US$ Million)
Table 80. GSK Recent Development
Table 81. Eli Lilly Company Details
Table 82. Eli Lilly Business Overview
Table 83. Eli Lilly Central Nervous System (CNS) Drug Product
Table 84. Eli Lilly Revenue in Central Nervous System (CNS) Drug Business (2016-2021) & (US$ Million)
Table 85. Eli Lilly Recent Development
Table 86. Teva Company Details
Table 87. Teva Business Overview
Table 88. Teva Central Nervous System (CNS) Drug Product
Table 89. Teva Revenue in Central Nervous System (CNS) Drug Business (2016-2021) & (US$ Million)
Table 90. Teva Recent Development
Table 91. Otsuka Pharmaceutical Co., Ltd Company Details
Table 92. Otsuka Pharmaceutical Co., Ltd Business Overview
Table 93. Otsuka Pharmaceutical Co., Ltd Central Nervous System (CNS) Drug Product
Table 94. Otsuka Pharmaceutical Co., Ltd Revenue in Central Nervous System (CNS) Drug Business (2016-2021) & (US$ Million)
Table 95. Otsuka Pharmaceutical Co., Ltd Recent Development
Table 96. Biogen Inc Company Details
Table 97. Biogen Inc Business Overview
Table 98. Biogen Inc Revenue in Central Nervous System (CNS) Drug Business (2016-2021) & (US$ Million)
Table 99. Biogen Inc Recent Development
Table 100. Boehringer Ingelheim Company Details
Table 101. Boehringer Ingelheim Business Overview
Table 102. Boehringer Ingelheim Central Nervous System (CNS) Drug Product
Table 103. Boehringer Ingelheim Revenue in Central Nervous System (CNS) Drug Business (2016-2021) & (US$ Million)
Table 104. Boehringer Ingelheim Recent Development
Table 105. Roche Company Details
Table 106. Roche Business Overview
Table 107. Roche Central Nervous System (CNS) Drug Product
Table 108. Roche Revenue in Central Nervous System (CNS) Drug Business (2016-2021) & (US$ Million)
Table 109. Roche Recent Development
Table 110. UCB Company Details
Table 111. UCB Business Overview
Table 112. UCB Central Nervous System (CNS) Drug Product
Table 113. UCB Revenue in Central Nervous System (CNS) Drug Business (2016-2021) & (US$ Million)
Table 114. UCB Recent Development
Table 115. Tekeda Company Details
Table 116. Tekeda Business Overview
Table 117. Tekeda Central Nervous System (CNS) Drug Product
Table 118. Tekeda Revenue in Central Nervous System (CNS) Drug Business (2016-2021) & (US$ Million)
Table 119. Tekeda Recent Development
Table 120. Shanghai Fosun Company Details
Table 121. Shanghai Fosun Business Overview
Table 122. Shanghai Fosun Central Nervous System (CNS) Drug Product
Table 123. Shanghai Fosun Revenue in Central Nervous System (CNS) Drug Business (2016-2021) & (US$ Million)
Table 124. Shanghai Fosun Recent Development
Table 125. Jiangsu Nhwa Pharmaceutical Co., Ltd. Company Details
Table 126. Jiangsu Nhwa Pharmaceutical Co., Ltd. Business Overview
Table 127. Jiangsu Nhwa Pharmaceutical Co., Ltd. Central Nervous System (CNS) Drug Product
Table 128. Jiangsu Nhwa Pharmaceutical Co., Ltd. Revenue in Central Nervous System (CNS) Drug Business (2016-2021) & (US$ Million)
Table 129. Jiangsu Nhwa Pharmaceutical Co., Ltd. Recent Development
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Central Nervous System (CNS) Drug Market Share by Type: 2020 VS 2027
Figure 2. Prescription Drugs Features
Figure 3. OTC Features
Figure 4. Global Central Nervous System (CNS) Drug Market Share by Application: 2020 VS 2027
Figure 5. MS Therapeutics Case Studies
Figure 6. Antipsychotic Drugs Case Studies
Figure 7. Depression Drugs Case Studies
Figure 8. Epilepsy Drugs Case Studies
Figure 9. Others Case Studies
Figure 10. Central Nervous System (CNS) Drug Report Years Considered
Figure 11. Global Central Nervous System (CNS) Drug Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Central Nervous System (CNS) Drug Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Central Nervous System (CNS) Drug Market Share by Regions: 2020 VS 2027
Figure 14. Global Central Nervous System (CNS) Drug Market Share by Regions (2022-2027)
Figure 15. Global Central Nervous System (CNS) Drug Market Share by Players in 2020
Figure 16. Global Top Central Nervous System (CNS) Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Central Nervous System (CNS) Drug as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Central Nervous System (CNS) Drug Revenue in 2020
Figure 18. Global Central Nervous System (CNS) Drug Revenue Market Share by Type (2016-2021)
Figure 19. Global Central Nervous System (CNS) Drug Revenue Market Share by Type (2022-2027)
Figure 20. North America Central Nervous System (CNS) Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Central Nervous System (CNS) Drug Market Share by Type (2016-2027)
Figure 22. North America Central Nervous System (CNS) Drug Market Share by Application (2016-2027)
Figure 23. North America Central Nervous System (CNS) Drug Market Share by Country (2016-2027)
Figure 24. United States Central Nervous System (CNS) Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Central Nervous System (CNS) Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Central Nervous System (CNS) Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Central Nervous System (CNS) Drug Market Share by Type (2016-2027)
Figure 28. Europe Central Nervous System (CNS) Drug Market Share by Application (2016-2027)
Figure 29. Europe Central Nervous System (CNS) Drug Market Share by Country (2016-2027)
Figure 30. Germany Central Nervous System (CNS) Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Central Nervous System (CNS) Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Central Nervous System (CNS) Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Central Nervous System (CNS) Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Central Nervous System (CNS) Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Central Nervous System (CNS) Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Central Nervous System (CNS) Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Central Nervous System (CNS) Drug Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Central Nervous System (CNS) Drug Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Central Nervous System (CNS) Drug Market Share by Region (2016-2027)
Figure 40. China Central Nervous System (CNS) Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Central Nervous System (CNS) Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Central Nervous System (CNS) Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Central Nervous System (CNS) Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Central Nervous System (CNS) Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Central Nervous System (CNS) Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Central Nervous System (CNS) Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Central Nervous System (CNS) Drug Market Share by Type (2016-2027)
Figure 48. Latin America Central Nervous System (CNS) Drug Market Share by Application (2016-2027)
Figure 49. Latin America Central Nervous System (CNS) Drug Market Share by Country (2016-2027)
Figure 50. Mexico Central Nervous System (CNS) Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Central Nervous System (CNS) Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Central Nervous System (CNS) Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Central Nervous System (CNS) Drug Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Central Nervous System (CNS) Drug Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Central Nervous System (CNS) Drug Market Share by Country (2016-2027)
Figure 56. Turkey Central Nervous System (CNS) Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Central Nervous System (CNS) Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Central Nervous System (CNS) Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Johnson & Johnson Revenue Growth Rate in Central Nervous System (CNS) Drug Business (2016-2021)
Figure 60. Pfizer Inc Revenue Growth Rate in Central Nervous System (CNS) Drug Business (2016-2021)
Figure 61. Novartis AG Revenue Growth Rate in Central Nervous System (CNS) Drug Business (2016-2021)
Figure 62. GSK Revenue Growth Rate in Central Nervous System (CNS) Drug Business (2016-2021)
Figure 63. Eli Lilly Revenue Growth Rate in Central Nervous System (CNS) Drug Business (2016-2021)
Figure 64. Teva Revenue Growth Rate in Central Nervous System (CNS) Drug Business (2016-2021)
Figure 65. Otsuka Pharmaceutical Co., Ltd Revenue Growth Rate in Central Nervous System (CNS) Drug Business (2016-2021)
Figure 66. Biogen Inc Revenue Growth Rate in Central Nervous System (CNS) Drug Business (2016-2021)
Figure 67. Boehringer Ingelheim Revenue Growth Rate in Central Nervous System (CNS) Drug Business (2016-2021)
Figure 68. Roche Revenue Growth Rate in Central Nervous System (CNS) Drug Business (2016-2021)
Figure 69. UCB Revenue Growth Rate in Central Nervous System (CNS) Drug Business (2016-2021)
Figure 70. Tekeda Revenue Growth Rate in Central Nervous System (CNS) Drug Business (2016-2021)
Figure 71. Shanghai Fosun Revenue Growth Rate in Central Nervous System (CNS) Drug Business (2016-2021)
Figure 72. Jiangsu Nhwa Pharmaceutical Co., Ltd. Revenue Growth Rate in Central Nervous System (CNS) Drug Business (2016-2021)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs